本文選題：骨髓基質(zhì)干細(xì)胞 + 內(nèi)源性腦腸肽��； 參考：《重慶醫(yī)科大學(xué)》2016年博士論文

【摘要】：骨髓基質(zhì)干細(xì)胞(bone marrow mesenchymal stem cells,BMSCs)是干細(xì)胞家族的主要成員,其最初在骨髓被發(fā)現(xiàn),它具有多項(xiàng)功能諸如,分化潛能,造血支持,免疫調(diào)節(jié)等。其增殖和分化為現(xiàn)如今的熱點(diǎn)。在1999年,Ghrelin被日本學(xué)者Kojima等發(fā)現(xiàn)。經(jīng)研究發(fā)現(xiàn),它是由28個氨基酸殘基組成,分子量為3.3KD。Ghrelin是生長激素促分泌素受體(Growth hormone secretagogue receptor,GHS-R)的內(nèi)源性配體,當(dāng)它與其受體GHS-R結(jié)合后會產(chǎn)生具有很強(qiáng)的促進(jìn)生長激素(Growth hormone,GH)釋放的作用。對MAPK途徑的研究主要表現(xiàn)在哺乳動物細(xì)胞中的研究,其主要方法是過表達(dá)、失活、基因沉默等方法。MAPK信號通路主要有4種類型,用它們的核心命名為MAPK。多種生理活動的調(diào)節(jié)均由其參與。每條通路都可以和其它通路相整合交叉,細(xì)胞的命運(yùn)主要由他們的信號強(qiáng)弱及活化程度決定。目的:本研究就ghrelin對兔BMSCs(rBMSCs)的增殖與分化的作用,及ghrelin通過哪種途徑來實(shí)現(xiàn)對兔BMSCs的增殖與分化的作用機(jī)制進(jìn)行研究。方法:從健康清潔新西蘭大白兔體內(nèi)分離純化得到rBMSCs。傳代后免疫熒光檢測rMSCs細(xì)胞標(biāo)記物CD44、CD34的表達(dá),用MTT檢測不同代的rmscs在10天內(nèi)的生長情況,從而得到最佳的生長時間。利用mtt法檢測不同濃度的ghrelin對rmscs的增殖作用,從而找到ghrelin對rmscs的增殖作用的最佳的作用濃度與作用時間。用westernblot的方法來檢測ghrelin對rmscs不同時間點(diǎn)的mapk通路的關(guān)鍵蛋白(erk1/2,p38和jnk)的磷酸化情況,來研究ghrelin發(fā)揮其作用的主要通路。為了進(jìn)一步研究ghrelin對rmscs增殖的作用,將mapk通路的關(guān)鍵蛋白進(jìn)行抑制,用westernblot來檢測其下游蛋白的磷酸化情況,及細(xì)胞增殖情況。同時用ghrelin受體抑制劑作用于細(xì)胞,用westernblot方法檢mapk通路的關(guān)鍵蛋白(erk1/2,p38和jnk)的磷酸化情況,用mtt法檢測細(xì)胞增殖情況。同時用ghrelin對rbmcs向成骨細(xì)胞分化的影響進(jìn)行研究。用westernblot檢測加入ghrelin后成骨細(xì)胞標(biāo)志因子alp,runx2和osterix的表達(dá)情況,同時檢測mapk通路的關(guān)鍵蛋白(erk1/2,p38和jnk)的磷酸化情況,來確定ghrelin對rbmcs向成骨細(xì)胞分化影響的作用機(jī)制。用mapk通路的關(guān)鍵蛋白的抑制劑作用于細(xì)胞,及ghrelin受體抑制劑作用于rbmcs向成骨細(xì)胞分化的過程,在分別檢測alp,runx2和osterix的表達(dá)情況。結(jié)果:由新西蘭大白兔提rmscs,經(jīng)培養(yǎng)得到較純的細(xì)胞,其在第四代的生長最佳,且cd44有強(qiáng)烈表達(dá),而cd34則沒有表達(dá)。ghrelin對rmscs有明顯的促進(jìn)生長的作用。ghrelin對rmscs的最佳作用濃度為600ng/ml,作用時間為第三天。用600ng/ml的ghrelin作用于rbmcs并于0,20,40和60min后,磷酸化的erk1/2的表達(dá)量在ghrelin作用后隨著作用時間的增加而增加(p0.05)。且在40min時達(dá)到量高而后保持不變(p0.05)。說明ghrelin對rbmcs的作用是通過erk1/2通路起作用的。為了進(jìn)一步證明erk1/2通路的做用,用erk1/2磷酸化抑制劑u0126作用細(xì)胞,發(fā)現(xiàn)ghrelin對細(xì)胞的促進(jìn)生長作用消失。當(dāng)細(xì)胞在600ng/mlghrelin的作用下,加入ghrelin受體抑制劑,抑制了細(xì)胞的生長。從而說明在ghrelin促進(jìn)rmscs生長增殖時也是ghrelin首先與其受體結(jié)合然后才發(fā)揮的促進(jìn)作用的。在本研究中將alp,runx2和osterix作為rbmscs向成骨細(xì)胞分化的檢測指標(biāo),結(jié)果表明在ghrelin存在的情況下,alp,runx2和osterix的表達(dá)量升高,更有利于rbmscs向成骨細(xì)胞分化。為了進(jìn)一步研究ghrelin促進(jìn)rbmscs向成骨細(xì)胞分化的作用機(jī)制,本研究對mapk通路的主要蛋白erk1/2,jnk和p38磷酸化情況進(jìn)行了檢測。結(jié)果表明ghrelin促進(jìn)rbmscs向成骨細(xì)胞分化主要是通過erk1/2通路來實(shí)現(xiàn)的,為了進(jìn)一步證明此機(jī)制,我們用erk1/2磷酸化抑制劑u0126作用于rbmscs,結(jié)果表明erk1/2磷酸化被抑制,而alp,runx2和osterix這三種蛋白的表達(dá)量均顯著下降,且低于只加地塞米松組的表達(dá)量,說明rbmscs向成骨細(xì)胞分化過程減慢。進(jìn)一步證明了ghrelin促進(jìn)rbmscs向成骨細(xì)胞分化主要是通過erk1/2通路來實(shí)現(xiàn)的。為了證明ghrelin促進(jìn)rbmscs向成骨細(xì)胞分化的實(shí)現(xiàn)是ghrelin先與其受體結(jié)合然后才發(fā)揮其作用的,本研究還用ghrelin受體抑制劑作用于rbmscs后磷酸化的erk1/2,jnk,p38的表達(dá)量在不同的時間段均沒有發(fā)生明顯的變化。同時檢測了細(xì)胞中alp,runx2和osterix的表達(dá)量也沒有變化。表明ghrelin的促進(jìn)作用受到抑制。結(jié)論:本研究證明了ghrelin促進(jìn)rbmscs向成骨細(xì)胞分化的機(jī)制是ghrelin先與其受體結(jié)合然后通過erk1/2通路促進(jìn)rbmscs的增殖及向成骨細(xì)胞分化的。
[Abstract]:Bone marrow stromal cells (bone marrow mesenchymal stem cells, BMSCs) are the main members of the stem cell family. Originally found in the bone marrow, it has a number of functions such as differentiation potential, hematopoiesis support and immunoregulation. Its proliferation and differentiation are now hot spots. In 1999, Ghrelin was found by Japanese scholar Kojima, and so on. The study found that the bone marrow stromal stem cells were found in 1999. It is composed of 28 amino acid residues, and the molecular weight of 3.3KD.Ghrelin is an endogenous ligand for the Growth hormone secretagogue receptor (GHS-R) receptor. When it is combined with its receptor GHS-R, it produces a strong role in promoting the release of growth hormone (Growth hormone, GH). The main table for the MAPK pathway is studied. Now the main methods in mammalian cells are over expression, inactivation, and gene silencing. The.MAPK signaling pathway is mainly 4 types, and the regulation of various physiological activities, named MAPK., is involved. Each pathway can be intersecting with other pathways, and the fate of the cells is mainly due to their strong signals. The purpose of this study is to study the effect of ghrelin on the proliferation and differentiation of rabbit BMSCs (rBMSCs), and the mechanism of the action mechanism of ghrelin on the proliferation and differentiation of rabbit BMSCs. Method: to isolate and purify New Zealand white rabbits from healthy and clean New Zealand white rabbits, and to detect rMSCs finely after rBMSCs. passages. The expression of cellular marker CD44, CD34, the growth of rMSCs in different generations in 10 days was detected by MTT, and the optimum growth time was obtained. The MTT method was used to detect the proliferation of ghrelin at different concentrations to rMSCs, and the optimum concentration and time of action of ghrelin to rMSCs proliferation was found. A Westernblot method was used to detect the effect of ghrelin on the proliferation of rMSCs. Ghrelin studies the phosphorylation of key proteins (erk1/2, p38 and JNK) of the MAPK pathway at different time points of rMSCs to study the main pathway of ghrelin to play its role. In order to further study the effect of ghrelin on rMSCs proliferation, the key proteins of the MAPK pathway are suppressed, and the phosphorylation of the downstream proteins in the MAPK pathway is detected by Westernblot. At the same time, the cell proliferation was detected by the ghrelin receptor inhibitor, and the phosphorylation of the key proteins (erk1/2, p38 and JNK) in the MAPK pathway was detected by the Westernblot method. The cell proliferation was detected by MTT method. The effect of ghrelin on the differentiation of rbmcs into osteoblasts was studied with ghrelin. Westernblot was used to detect the osteoblasts after ghrelin. The expression of marker factors ALP, Runx2 and osterix, and the phosphorylation of key proteins (erk1/2, p38 and JNK) of the MAPK pathway to determine the mechanism of ghrelin's effect on the differentiation of rbmcs into osteoblast. The inhibitor of the key protein of the MAPK pathway acts on the cells, and the ghrelin receptor inhibitor acts on the rbmcs to osteoblasts. The process of differentiation, the expression of ALP, Runx2 and osterix were detected respectively. Results: a New Zealand white rabbit was given rMSCs and cultured to obtain more pure cells. The growth of the fourth generation was the best, and CD44 had a strong expression, while CD34 did not express the effect of.Ghrelin on rMSCs. The best concentration of.Ghrelin for rMSCs was the concentration of CD34. 600ng/ml, the action time is third days. The expression of phosphorylated erk1/2 is increased after ghrelin action with the action of 600ng/ml ghrelin on rbmcs and after 0,20,40 and 60min (P0.05). And it reaches a high quantity at 40min and then remains unchanged (P0.05). In order to further prove the use of the erk1/2 pathway and use the erk1/2 phosphorylation inhibitor U0126 to act on the cells, it is found that ghrelin can promote the growth of the cells. When the cells are under the action of 600ng/mlghrelin, the ghrelin receptor inhibitors are added to inhibit the growth of the cells. Thus, it is said that ghrelin promotes rMSCs proliferation and ghrelin in ghrelin. In this study, ALP, Runx2 and osterix were used as an indicator of rBMSCs differentiation to osteoblasts in this study. The results showed that, in the presence of ghrelin, the expression of ALP, Runx2 and osterix increased, which was more conducive to the differentiation of rBMSCs into osteoblasts. In order to further study ghrelin to promote RB. The mechanism of MSCs to osteoblast differentiation, this study examines the major protein erk1/2, JNK and p38 phosphorylation of the MAPK pathway. The results show that ghrelin promotes the differentiation of rBMSCs into osteoblasts mainly through erk1/2 pathway. In order to further prove this mechanism, we use erk1/2 phosphorylation inhibitor U0126 to act on RBMs. CS, the results showed that the phosphorylation of erk1/2 was inhibited, and the expression of the three proteins of ALP, Runx2 and osterix were significantly decreased, and lower than that of only dexamethasone group, which indicated that rBMSCs slowed down the differentiation process of osteoblasts. It further proved that ghrelin promotes rBMSCs to osteogenic cell differentiation mainly through erk1/2 pathway. It is demonstrated that ghrelin promotes the differentiation of rBMSCs into osteoblasts by combining ghrelin with its receptor before playing its role. This study also uses the ghrelin receptor inhibitor to phosphorylate erk1/2 after rBMSCs, JNK, and p38 has no significant changes at different time periods. At the same time, ALP, Runx2 and OSTE in cells are detected. The expression of Rix has not changed. It shows that the promoting effect of ghrelin is inhibited. Conclusion: This study demonstrated that the mechanism of ghrelin to promote the differentiation of rBMSCs into osteoblasts is that ghrelin combines with its receptor first and promotes the proliferation of rBMSCs through the erk1/2 pathway and differentiation into osteoblasts.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級別】：博士
【學(xué)位授予年份】：2016
【分類號】：R329.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 苗培;楊國宇;惠永華;;Ghrelin的研究進(jìn)展[J];乳業(yè)科學(xué)與技術(shù);2007年01期

2 呂善潮;張勝利;;Ghrelin及相關(guān)基因的研究進(jìn)展[J];上海畜牧獸醫(yī)通訊;2007年03期

3 王麗曄;李峰;宋月晗;馬佳美;李思耐;關(guān)冰河;;Ghrelin發(fā)現(xiàn)和結(jié)構(gòu)的研究現(xiàn)狀[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2011年18期

4 李雙月,孫長凱;Ghrelin研究及其臨床意義[J];國外醫(yī)學(xué)(生理、病理科學(xué)與臨床分冊);2003年02期

5 曹貴方,呂東媛,白春玲,火焱,旭日干;一種新的腦腸肽激素——Ghrelin[J];畜牧與飼料科學(xué);2004年06期

6 黃治國,熊俐,劉振山,劉守仁,謝莊,劉國慶;Ghrelin—一種多功能激素[J];中國畜牧獸醫(yī);2005年08期

7 陳斌,吳天星;Ghrelin生物學(xué)功能的研究進(jìn)展[J];中國畜牧雜志;2005年10期

8 肖園;王偉;;Ghrelin與生長激素關(guān)系的研究進(jìn)展[J];國外醫(yī)學(xué).內(nèi)分泌學(xué)分冊;2005年06期

9 火焱;楊銀鳳;;腦腸肽ghrelin的研究進(jìn)展[J];中國獸醫(yī)科學(xué);2006年03期

10 高慶;張克英;;Ghrelin:一個重要腦腸肽生物學(xué)效應(yīng)的研究進(jìn)展[J];中國畜牧雜志;2006年07期

相關(guān)會議論文 前10條

1 聶慶華;方梅霞;張細(xì)權(quán);;動物生長素(Ghrelin)基因的比較分析[A];第十次全國畜禽遺傳標(biāo)記研討會論文集[C];2006年

2 陳黎龍;江青艷;張永亮;;Ghrelin與動物的采食調(diào)控[A];全國動物生理生化第十次學(xué)術(shù)交流會論文摘要匯編[C];2008年

3 趙潔;張金山;李臻;張遠(yuǎn)強(qiáng);;Ghrelin在小鼠應(yīng)激性胸腺萎縮中的表達(dá)及其意義[A];中國解剖學(xué)會第十一屆全國組織學(xué)與胚胎學(xué)青年學(xué)術(shù)研討會論文匯編[C];2009年

4 陳黎龍;江青艷;傅偉龍;;Ghrelin及其受體研究概況[A];動物生理生化學(xué)分會第八次學(xué)術(shù)會議暨全國反芻動物營養(yǎng)生理生化第三次學(xué)術(shù)研討會論文摘要匯編[C];2004年

5 林浩然;;Ghrelin:結(jié)構(gòu)、分布和生理功能[A];第二屆中國動物學(xué)會比較內(nèi)分泌學(xué)分會和發(fā)育生物學(xué)分會聯(lián)合學(xué)術(shù)研討會論文集[C];2005年

6 火焱;楊銀鳳;王秀梅;;生長素-Ghrelin的研究進(jìn)展[A];中國畜牧獸醫(yī)學(xué)會動物解剖學(xué)及組織胚胎學(xué)分會第十四次學(xué)術(shù)研討會論文集[C];2006年

7 李樂;張佳林;李曉航;張城碩;程穎;趙寧;劉永鋒;;Ghrelin對地塞米松誘導(dǎo)胰島細(xì)胞凋亡保護(hù)作用的研究[A];2012中國器官移植大會論文匯編[C];2012年

8 李玉姝;金本巨哲;有安宏之;巖倉浩;中尾一和;赤水尚史;;甲狀腺激素對Ghrelin基因轉(zhuǎn)錄和分泌的影響[A];2008中國醫(yī)師協(xié)會內(nèi)分泌代謝科醫(yī)師分會年會論文匯編[C];2008年

9 胡翠竹;胡健;霍海洋;趙衛(wèi)華;;Ghrelin抑制尼古丁誘導(dǎo)的人臍靜脈內(nèi)皮細(xì)胞趨化因子的表達(dá)[A];中華醫(yī)學(xué)會第11次心血管病學(xué)術(shù)會議論文摘要集[C];2009年

10 蘇娟;雷治海;張文龍;武楓林;施玉萍;姚遠(yuǎn);楊桂紅;;Ghrelin對豬生殖調(diào)節(jié)的體外研究[A];中國畜牧獸醫(yī)學(xué)會動物解剖學(xué)及組織胚胎學(xué)分會第十六次學(xué)術(shù)研討會論文集[C];2010年

相關(guān)重要報紙文章 前1條

1 崔翔宇;Ghrelin：其結(jié)構(gòu)及生理學(xué)的重要性 Discovery of Ghrelin：Its Structure and Physiological Significance[N];中國醫(yī)藥報;2006年

相關(guān)博士學(xué)位論文 前10條

1 葉博;短鏈脂肪酸促進(jìn)人和小鼠gastroids中產(chǎn)ghrelin細(xì)胞分化和小鼠胃排空的生理機(jī)制研究[D];第二軍醫(yī)大學(xué);2015年

2 周利;電針對Ghrelin介導(dǎo)的FD大鼠腦腸軸失衡調(diào)節(jié)作用的實(shí)驗(yàn)研究[D];湖北中醫(yī)藥大學(xué);2015年

3 吳志勤;1.Ghrelin對糖尿病心肌病大鼠心功能保護(hù)效應(yīng)及機(jī)制研究 2.大黃素對糖尿病心肌病大鼠心功能保護(hù)效應(yīng)及機(jī)制研究[D];重慶醫(yī)科大學(xué);2015年

4 葉楠;Ghrelin通過MAPK通路誘導(dǎo)兔BMSCs增殖及成骨分化的機(jī)制研究[D];重慶醫(yī)科大學(xué);2016年

5 萬晶晶;Ghrelin對巨噬細(xì)胞源性泡沫細(xì)胞形成的抑制作用及其機(jī)制研究[D];華中科技大學(xué);2009年

6 王彥富;Ghrelin抗動脈粥樣硬化的基礎(chǔ)與臨床研究[D];華中科技大學(xué);2009年

7 董靜;Ghrelin在糖尿病小鼠攝食調(diào)節(jié)與能量平衡中的作用[D];青島大學(xué);2005年

8 許嶺翎;Ghrelin基因多態(tài)性與2型糖尿病及其危險因素的相關(guān)性研究[D];中國協(xié)和醫(yī)科大學(xué);2006年

9 杜改梅;斷奶仔豬胃腸道Ghrelin表達(dá)及其對胃功能的調(diào)節(jié)[D];南京農(nóng)業(yè)大學(xué);2006年

10 楊丹;Ghrelin對肺動脈內(nèi)皮細(xì)胞損傷的保護(hù)作用及其與內(nèi)皮舒縮分子關(guān)系的研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

相關(guān)碩士學(xué)位論文 前10條

1 劉麗麗;原發(fā)性高血壓患者血清Ghrelin和Hcy水平的變化及其臨床意義[D];河北醫(yī)科大學(xué);2015年

2 黃雅懔;逍遙散對焦慮癥大鼠胃腸道Ghrelin和Obestatin含量表達(dá)的調(diào)節(jié)作用[D];北京中醫(yī)藥大學(xué);2016年

3 毛蘭芳;平胃膠囊治療肝郁脾虛型FD的臨床觀察及對CCK、Ghrelin影響的實(shí)驗(yàn)研究[D];甘肅中醫(yī)藥大學(xué);2016年

4 李志平;四種證型慢性胃炎患者胃粘膜腦腸肽-Ghrelin、SST、MTL、GAS表達(dá)水平的研究[D];甘肅中醫(yī)藥大學(xué);2016年

5 張娜;牦牛Ghrelin對其極端生境適應(yīng)的分子機(jī)理[D];蘭州大學(xué);2016年

6 左旭陽;血清Ghrelin與單純糖尿病、代謝正常肥胖及代謝綜合征患者執(zhí)行功能的相關(guān)性研究[D];安徽醫(yī)科大學(xué);2016年

7 張曼;馴鹿Ghrelin基因克隆及其在各器官內(nèi)的表達(dá)定位研究[D];內(nèi)蒙古農(nóng)業(yè)大學(xué);2016年

8 宮冰;Ghrelin對體外培養(yǎng)的中腦神經(jīng)干細(xì)胞增殖和分化的影響[D];青島大學(xué);2016年

9 沈兆星;Ghrelin通過影響Dkk-1的表達(dá)調(diào)控WNT信號通路改善糖尿病大鼠認(rèn)知功能[D];重慶醫(yī)科大學(xué);2016年

10 郭銳;殼聚糖納米粒介導(dǎo)豬Ghrelin基因?qū)π∈笊L的影響[D];華中農(nóng)業(yè)大學(xué);2008年

，

本文編號：1946494